OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
Qiao‐Hong Chen, Erick Munoz, Dennis Ashong
Cancers (2024) Vol. 16, Iss. 3, pp. 663-663
Open Access | Times Cited: 15
Qiao‐Hong Chen, Erick Munoz, Dennis Ashong
Cancers (2024) Vol. 16, Iss. 3, pp. 663-663
Open Access | Times Cited: 15
Showing 15 citing articles:
PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 8
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 8
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Cancer Drug Resistance (2025)
Open Access
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Cancer Drug Resistance (2025)
Open Access
Novel hormone therapies for advanced prostate cancer: understanding and countering drug resistance
Zhipeng Wang, Jie Wang, Dengxiong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101232-101232
Open Access
Zhipeng Wang, Jie Wang, Dengxiong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101232-101232
Open Access
Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer’s Disease
Qiuzhi Zhou, Weixia Wang, Chunchu Deng
Molecular Neurobiology (2025)
Open Access
Qiuzhi Zhou, Weixia Wang, Chunchu Deng
Molecular Neurobiology (2025)
Open Access
Advances in designing ternary complexes: Integrating in-silico and biochemical methods for PROTAC optimisation in target protein degradation
Shareef Shaik, Prasanna Kumar Reddy Gayam, Manish Chaudhary, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107868-107868
Open Access | Times Cited: 3
Shareef Shaik, Prasanna Kumar Reddy Gayam, Manish Chaudhary, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107868-107868
Open Access | Times Cited: 3
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium
Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies
Jingsong Zhang, Juskaran Chadha
Cancers (2024) Vol. 16, Iss. 17, pp. 3098-3098
Open Access | Times Cited: 2
Jingsong Zhang, Juskaran Chadha
Cancers (2024) Vol. 16, Iss. 17, pp. 3098-3098
Open Access | Times Cited: 2
Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment
Carly D. Miller, Pornlada Likasitwatanakul, Eamon Toye, et al.
Expert Review of Anticancer Therapy (2024)
Closed Access | Times Cited: 2
Carly D. Miller, Pornlada Likasitwatanakul, Eamon Toye, et al.
Expert Review of Anticancer Therapy (2024)
Closed Access | Times Cited: 2
FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives
Heba M. Hesham, Eman M.E. Dokla, Eman Z. Elrazaz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116717-116717
Closed Access | Times Cited: 1
Heba M. Hesham, Eman M.E. Dokla, Eman Z. Elrazaz, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116717-116717
Closed Access | Times Cited: 1
Chemoproteomic Covalent Ligand Discovery as the PROTAC-gonist: The Future of Targeted Degradation Medicines
Kyosuke Shishikura, Megan L. Matthews
ACS Central Science (2024) Vol. 10, Iss. 7, pp. 1314-1317
Open Access
Kyosuke Shishikura, Megan L. Matthews
ACS Central Science (2024) Vol. 10, Iss. 7, pp. 1314-1317
Open Access
Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies
M M Rahman, Khadija Akter, Kazi Rejvee Ahmed, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2777-2777
Open Access
M M Rahman, Khadija Akter, Kazi Rejvee Ahmed, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2777-2777
Open Access
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Prostate cancer and genetic contributions
Wesley H. Chou, Cameron Chalker, Alexandra Sokolova, et al.
Andrology (2024)
Open Access
Wesley H. Chou, Cameron Chalker, Alexandra Sokolova, et al.
Andrology (2024)
Open Access
Formulation Development, Evaluation and Profound Biological Activity of Polyherbal Gel containing Vigna radiate, <i>Aloe barbidenis</i> and <i>Moringa oleifera</i>
Muhammad Tajammal Khan, Simranjeet, Sofia Pasi, et al.
International Journal of Newgen Research in Pharmacy & Healthcare (2024), pp. 142-148
Closed Access
Muhammad Tajammal Khan, Simranjeet, Sofia Pasi, et al.
International Journal of Newgen Research in Pharmacy & Healthcare (2024), pp. 142-148
Closed Access
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities
G. Paolo Dotto, An Buckinx, Berna C. Özdemir, et al.
Nature reviews. Cancer (2024)
Closed Access
G. Paolo Dotto, An Buckinx, Berna C. Özdemir, et al.
Nature reviews. Cancer (2024)
Closed Access
